ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), characterized by negative expression of estrogen, progesterone, and human epidermal growth factor receptor-2 [4], is the most aggressive breast malignancy, accounting for 19% of all types of breast cancer in Chinese patients [5].